Glaxo onboards promotional doctors

Share this article:

GlaxoSmithKline made a bit of a wave when it announced in December that it would no longer pay doctors to promote its drugs or to attend medical conferences.

Now comes part two: While Glaxo will not pay external doctors to talk up its drugs, it will hire doctor employees who will then go out into the field to discuss the company's drugs, reports Bloomberg.

Bloomberg reports that the new strategy will result in fewer doctors talking on GSK's behalf, and that this new crew has an added benefit: no need to report these payments under the Sunshine Act because these physicians work for GSK and are not presented as a disinterested party. Bloomberg posits this may knock GSK PhDs into being equated with medical science liaisons because these doctors will not be able to offer medical advice and are not practicing physicians.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Imbruvica lassoes CLL indication

The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Reckitt Benckiser wants out of pharma

The company plans to spin off its pharmaceutical unit.